«We
wondered whether we could make a safer and more tolerable form of DON by enhancing its
brain penetration and limiting its exposure to the rest of the body and, thus, toxicity,» says Barbara Slusher, Ph.D., professor of neurology, medicine, psychiatry, neuroscience and oncology at the Johns Hopkins University School of Medicine and director of Johns Hopkins
Drug Discovery.
If media reports of a «
wonder -
drug» that could «stop all neurodegenerative
brain diseases, including dementia» seem too good to be true, that's because they are.